Emerging studies suggest that heavily processed foods trigger elevated insulin responses even without significant blood sugar increases, raising concerns over their role in insulin resistance and diabetes risk. Ultra-processed foods may do more than simply add calories to the diet:…
Illinois Governor JB Pritzker has disclosed that he has been using a GLP-1 medication for the past two years to manage his type 2 diabetes, resulting in an 80-pound weight loss and significant health benefits. His candid sharing aims to…
Surrozen has received FDA approval to test SZN-8141, a promising bifunctional antibody aimed at tackling diabetic macular edema. Early results are expected in 2027, marking a significant step in retinal disease treatment development. The U.S. Food and Drug Administration has…
Waking up multiple times during the night to urinate might be normal after alcohol or caffeine, but persistent nocturia warrants medical attention to explore causes such as high blood sugar, bladder problems, or sleep apnoea. Waking up once in the…
Emerging research suggests that extra-virgin olive oil and nopal, the prickly pear cactus leaf, may support blood glucose regulation through enhancing GLP-1 hormone response, offering potential dietary tools within comprehensive diabetes management. Interest in foods that may help blunt blood…
A Buzz Health survey reveals a surge in patients opting to pay out-of-pocket for GLP-1 therapies, driven by convenience and new distribution channels, challenging traditional insurance models and signalling a consumer-led healthcare shift. More patients are paying cash for GLP-1…
In a significant breakthrough, Eli Lilly’s oral GLP-1 drug orforglipron demonstrated superior blood sugar control and weight loss compared to oral semaglutide in a 52-week phase 3 trial, potentially expanding treatment options for adults with type 2 diabetes. Eli Lilly’s…
Displaced individuals with type 1 diabetes face heightened risks as conflict disrupts access to insulin and essential supplies, exposing urgent gaps in emergency healthcare amid ongoing global crises. Living with type 1 diabetes means treating insulin, monitoring supplies and food…
New research highlights how calpains, calcium-activated enzymes, impair cellular waste disposal in blood vessel cells under diabetic conditions, offering a promising target for preventing vascular damage. A new study in Cellular and Molecular Life Sciences suggests that calpains, a family…
As GLP-1 therapies become more common for type 2 diabetes management, experts emphasise the importance of tailored nutritional strategies to address appetite suppression, gut side effects, and dietary gaps, highlighting new approaches to optimise health outcomes. People taking GLP-1 medicines…
